Search results
Results from the WOW.Com Content Network
David Andrew Sinclair AO (born June 26, 1969) is an Australian-American biologist and academic known for his research on aging and epigenetics.Sinclair is a professor of genetics at Harvard Medical School and the founding director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard.
A review for Boston Magazine called Sinclair "one of science's most controversial figures" and said many in the scientific community were skeptical of claims he made about human longevity. University of Alabama biology professor Steven N. Austad said, "David is a good friend, but I do think he's been guilty of making excessive claims."
Guarente's rivalry with Sinclair, which began in 2002 when Sinclair challenged Guarante's description of how sir2 might be involved in aging at a scientific meeting at Cold Spring Harbor Laboratory, was the subject of an article in Science in 2004. [20] In 2014 Guarente co-founded the dietary supplement company Elysium Health. [13] [21]
Getting diagnosed with type 2 diabetes before the age of 50 may increase one's risk of developing dementia by 1.9 times, a new study has found.
David Sinclair and Rachel Drake shattered records in winning the men's and women's titles in the 62nd annual JFK 50 Mile ultramarathon on Saturday. Sinclair, 32, of South Burlington, Vermont, took ...
Corresponding author Jonathan G. Hakun, PhD, an assistant professor of neurology, psychology, and public health sciences at Penn State, explained for Medical News Today how technology made this ...
OvaScience was a publicly traded biotechnology company, focused on female infertility.It was founded in 2011 by Michelle Dipp, Richard Aldrich, Christoph Westphal, Jonathan Tilly, and David Sinclair and is based on scientific work done by Tilly concerning mammalian oogonial stem cells and work on mitochondria by Sinclair.
In 1991, he began his undergraduate studies in life sciences at Bar Ilan University, which he graduated summa laude in 1994. From 1994 to 1999 he studied genetics under the supervision of Giora Simhan in a direct-path Ph.D program and from 1999 to 2004, studied postdoctoral studies at Harvard Medical School in Boston under the supervision of David Sinclair.